ニュース

News

Ann Meulemans and AbolerIS Pharma’s (Newton Biocapital’s Portfolio Company) remarkable journey to Gosselies to raise an impressive 27.3 million euros. Join us in the fight against inflammatory and autoimmune diseases!

More Info:

https://www.linkedin.com/feed/update/urn:li:activity:7109545643689340930?updateEntityUrn=urn%3Ali%3Afs_feedUpdate%3A%28V2%2Curn%3Ali%3Aactivity%3A7109545643689340930%29

https://www.tijd.be/ondernemen/farma-biotech/vlaamse-ceo-verhuist-met-frans-biotechbedrijf-naar-belgie/10493436